You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 69 No. 4, APRIL 1942 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

EXCRETION OF COPROPORPHYRIN IN HEPATIC DISEASE

CORRELATION OF URINARY AND FECAL EXCRETION WITH PARENCHYMATOUS HEPATIC DAMAGE

SAMUEL NESBITT, M.D.; ALBERT M. SNELL, M.D.

Arch Intern Med. 1942;69(4):573-581.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Porphyrins are red pigment substances, the chemical structure of which is based on a ring formed by four pyrrole nuclei which are connected in the form of a closed system by four methine bridges. It has long been recognized1 that small amounts of porphyrin are excreted normally in the urine of healthy persons and that these amounts may be increased in the urine of patients suffering from a variety of diseases. Porphyrinuria (increased proportion of porphyrin in the urine) has been described as accompanying many forms of hepatic disease,2 including cinchophen hepatitis, atrophic cirrhosis, obstructive jaundice, chronic passive congestion, lymphosarcoma of the liver, infectious icterus, melanosarcoma of the liver, hemolytic icterus and hemochromatosis.

It has been suggested that porphyrinuria observed in the presence of various other diseases and toxic states is caused by associated hepatic damage or dysfunction.3 Much evidence has accumulated which would indicate that porphyrin . . . [Full Text PDF of this Article]


Author Affiliations

Instructor in Medicine, Yale University School of Medicine NEW HAVEN, CONN.; ROCHESTER, MINN.

From the Division of Medicine (Dr. Snell), the Mayo Clinic.


Footnotes

Abstract of a portion of the thesis submitted by Dr. Samuel Nesbitt to the faculty of the Graduate School of the University of Minnesota in partial fulfilment of the requirements for the degree of Doctor of Philosophy in medicine.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1942 American Medical Association. All Rights Reserved.